Click here to register, call number +32 (0)2 620 01 38 Ablynx (EURONEXT BRUSSELS: ABLX) today announced efficacy and safety data for its anti-IL-6R Nanobody, ALX-0061, at the 24 week final analysis of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results